Helping clients meet their business challenges begins with an in-depth understanding of the industries in which they work. That’s why KPMG LLP established its industry-driven structure. In fact, KPMG LLP was the first of the Big Four firms to organize itself along the same industry lines as clients.

How We Work

We bring together passionate problem-solvers, innovative technologies, and full-service capabilities to create opportunity with every insight.

Learn more

Careers & Culture

What is culture? Culture is how we do things around here. It is the combination of a predominant mindset, actions (both big and small) that we all commit to every day, and the underlying processes, programs and systems supporting how work gets done.

Learn more

FCPA and anti-corruption strategies for the life sciences industry


Life sciences companies have been one of the most regulated industries over the past 10 to 15 years, with a significant number of Foreign Corrupt Practices Act (FCPA) enforcements in total. There are prevalent signals in both messaging and actions from regulators that indicate a potential significant increase in enforcement. The U.S. deputy attorney general indicated that corruption and white-collar crime is a priority of the Biden administration, noting a ramp-up of additional resources to the criminal division’s fraud section, which is tasked with investigating FCPA cases.

In the Risk and Compliance magazine mini-roundtable interview, KPMG Forensic panelists answer some of the top questions on FCPA and anti-corruption strategies for the life sciences industry. The mini-roundtable covers:

  • Recent enforcement action under the Foreign Corrupt Practices Act (FCPA)
  • Trends in the authorities’ approach and intent
  • Steps life sciences companies should consider when designing, implementing, monitoring, and updating their anti-corruption framework
  • Specific considerations life sciences companies should make to mitigate FCPA cases involving third-party intermediaries
  • Importance of boardroom buy-in when creating and rolling out anti-corruption strategies
  • Essential advice for life sciences companies to ensure they maintain on-going compliance
  • Predictions for the bribery and corruption challenges life companies will face in the coming months and years

Drive into our thinking:

FCPA and Anti-Corruption Strategies for the Life Sciences Industry

Download PDF

Explore more

Client Story

Following the data where others couldn’t

A specialized KPMG team brings forensic risk assessment and data analytics to an internal bribery investigation.


Following the data where others couldn’t

Read more

Thank you!

Thank you for contacting KPMG. We will respond to you as soon as possible.

Contact KPMG

Use this form to submit general inquiries to KPMG. We will respond to you as soon as possible.

By submitting, you agree that KPMG LLP may process any personal information you provide pursuant to KPMG LLP's Privacy Statement.

An error occurred. Please contact customer support.

Job seekers

Visit our careers section or search our jobs database.

Submit RFP

Use the RFP submission form to detail the services KPMG can help assist you with.

Office locations

International hotline

You can confidentially report concerns to the KPMG International hotline

Press contacts

Do you need to speak with our Press Office? Here's how to get in touch.